Oculis Holding AG (OCS) Cash from Investing Activities (2022 - 2024)

Oculis Holding AG's (OCS) quarterly Cash from Investing Activities came in at -$19.7 million in Q2 2024, down 738.58% quarter-over-quarter from -$2.3 million in Q1 2024.

Oculis Holding AG (OCS) Cash from Investing Activities (2022 - 2024) Analysis & Trends

Oculis Holding AG's Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$19.7 million for Q2 2024.

  • On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$19.7 million in Q2 2024; TTM through Jun 2024 was -$464875.5, a N/A change from a year earlier, with the FY2025 full-year figure at -$73.5 million, down 302.01% from the prior year.
  • Cash from Investing Activities declined to -$19.7 million in Q2 2024 per OCS's latest filing, from -$2.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $25.9 million in Q4 2023 and bottomed at -$19.7 million in Q2 2024.
  • The 3-year median for Cash from Investing Activities is -$2.0 million (2024), against an average of -$427938.7.
  • Biggest YoY gain for Cash from Investing Activities was 1744.57% in 2023; the steepest drop was 714.06% in 2023.
  • Year by year, Cash from Investing Activities stood at -$1.6 million in 2022, then jumped by 1744.57% to $25.9 million in 2023, then sank by 176.04% to -$19.7 million in 2024.
  • Per Business Quant, the three latest OCS Cash from Investing Activities figures stand at -$19.7 million (Q2 2024), -$2.3 million (Q1 2024), and $25.9 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 172.62 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn -25.54 Mn

Historic Data

Download Data
DateValue
Jun 30, 2024 -19.67 Mn
Jun 30, 2024 -19.67 Mn
Mar 31, 2024 -2.35 Mn
Mar 31, 2024 -2.35 Mn
Dec 31, 2023 25.86 Mn
Dec 31, 2023 25.86 Mn
Sep 30, 2023 -4.32 Mn
Sep 30, 2023 -4.32 Mn
Dec 31, 2022 -1.57 Mn
Dec 31, 2022 -1.57 Mn
Sep 30, 2022 -530,153.80
Sep 30, 2022 -530,153.80